RFK Jr. has withdrawn his support for mRNA vaccines, affecting bio-tech firms such as Moderna and causing a downturn in their stock prices. This also involves the cancellation of nearly $500 million in mRNA vaccine contracts. However, IBM and Moderna advanced their research on mRNA by simulating the longest pattern without AI but using quantum computing. Despite funding holds, mRNA vaccines continue to show promise with Moderna recently announcing promising efficacy results from their flu vaccine trial. However, Moderna’s stock took a hit after Mr. Kennedy's actions and a decrease in vaccine demand, causing the company to lower their sales forecast and scrap plans for establishing an mRNA plant in Japan. Concurrently, Moderna has been successful in a patent case against Pfizer and BioNTech in the UK and a trial showing Moderna's mRNA-1010 Flu Vaccine achieving efficacy goals in adults over 50. Further, Moderna has been awarded a significant amount by HHS to develop mRNA vaccines against flu threats. Another significant development is the FDA’s full approval for mRNA-1273 COVID-19 vaccine.
Moderna MRNA News Analytics from Fri, 25 Oct 2024 07:00:00 GMT to Sat, 09 Aug 2025 22:35:44 GMT -
Rating -5
- Innovation 3
- Information 6
- Rumor -2
